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Depression in small-vessel disease relates to
white matter ultrastructural damage, not
disability
ABSTRACT
Objective: To determine whether cerebral small-vessel disease (SVD) is a specific risk factor for
depression, whether any association is mediated via white matter damage, and to study the role
of depressive symptoms and disability on quality of life (QoL) in this patient group.
Methods: Using path analyses in cross-sectional data, we modeled the relationships among depres-
sion, disability, and QoL in patients with SVD presenting with radiologically confirmed lacunar stroke
(n 5 100), and replicated results in a second SVD cohort (n 5 100). We then compared the same
model in a non-SVD stroke cohort (n 5 50) and healthy older adults (n 5 203). In a further study, to
determine the role of white matter damage in mediating the association with depression, a subgroup
of patients with SVD (n 5 101) underwent diffusion tensor imaging (DTI).
Results: Reduced QoL was associated with depression in patients with SVD, but this association
was not mediated by disability or cognition; very similar results were found in the replication SVD
cohort. In contrast, the non-SVD stroke group and the healthy older adult group showed a direct
relationship between disability and depression. The DTI study showed that fractional anisotropy,
a marker of white matter damage, was related to depressive symptoms in patients with SVD.
Conclusion: These results suggest that in stroke patients without SVD, disability is an important
causal factor for depression, whereas in SVD stroke, other factors specific to this stroke subtype
have a causal role. White matter damage detected on DTI is one factor that mediates the associ-
ation between SVD and depression. Neurology® 2014;83:1417–1423
GLOSSARY
ADL 5 Activities of Daily Living; BMET 5 Brief Memory and Executive Test; CI 5 confidence interval; DTI 5 diffusion tensor
imaging; EPI 5 echo planar image; FA 5 fractional anisotropy; GDS 5 Geriatric Depression Scale; IADL 5 Instrumental
Activities of Daily Living; mRS 5 modified Rankin Scale; QoL 5 quality of life; SCANS 5 St George’s Cognition and Neuro-
imaging in Stroke; SSQoL 5 Stroke-Specific Quality of Life Scale; SVD 5 small-vessel disease.
Cerebral small-vessel disease (SVD) results from damage to small perforating end arteries sup-
plying white matter and subcortical gray matter, and is characterized by lacunar infarcts and leu-
koaraiosis. Common features include lacunar stroke, cognitive impairment, and reduced quality
of life (QoL).1,2 More recently, depression3 has been associated with SVD, and can occur before
the onset of other symptoms.4
It has been hypothesized that SVD may predispose individuals to depression by disruption of
cortical-subcortical circuits underlying mood.5 White matter lesions are more common in late-
onset depression compared with nondepressed controls,6–8 and lacunar infarcts and leukoaraiosis
are risk factors for chronic poststroke depression.9–11 However, not all studies confirm these
associations12–15; one possible reason is that other variables, such as physical disability and
cognitive impairment, may mediate the relationship between stroke and depression.16
Depression is common after all subtypes of stroke, and relates to the degree of disability.17 If
SVD has a specific causal role in depression via disruption of cortical-subcortical circuits, one
would predict an association between depression and SVD stroke that persists after controlling
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for the degree of physical disability. However, in
non-SVD stroke, depression would be related to
the degree of physical disability with the associa-
tion attenuated after controlling for disability. To
address this question, we first compared struc-
tural equation models of depression in SVD
and non-SVD stroke samples. Next, we used dif-
fusion tensor imaging (DTI) to investigate the
hypothesis that the SVD-depression association
is mediated by white matter damage.
METHODS Study design. Cross-sectional observational
investigation of structural equation models in SVD, non-SVD
stroke, and healthy control groups.
SVD population. SVD was defined as a clinical lacunar stroke
syndrome18 with radiologic (MRI) confirmation of an anatomically
corresponding lacunar infarct seen on diffusion-weighted imaging
for acute MRI, or for nonacute MRI (.2 weeks poststroke) by a
hypodense region on T1 or fluid-attenuated inversion recovery
sequences consistent with lacunar infarction of ,1.5 cm
diameter. Exclusion criteria included inability or unwillingness to
consent, and evidence of any stroke mechanism other than SVD:
any cortical infarction, subcortical infarcts .1.5 cm in diameter,
cardioembolic source, and extracranial or intracranial large-artery
stenosis (.50%). For all patients with SVD, assessments were
performed .3 months poststroke to reduce acute effects of
ischemia on cognitive and other measures. Two SVD cohorts
(discovery and replication) were recruited. Both had identical
inclusion and exclusion criteria. Thirty percent of all patients
with SVD met the Geriatric Depression Scale (GDS) criteria for
depression.19 Sample size for the discovery cohort was chosen to
provide a sample comparable to that used in a previous report on
depression in SVD.3
Discovery cohort. One hundred patients (60 male; mean
[SD] age 71.1 [8.5] years) were recruited from specialized stroke
services in 3 district hospitals in South London, UK, between
March 2007 and September 2009. These formed part of the early
recruitment to the St George’s Cognition and Neuroimaging in
Stroke (SCANS20) Study and the Brief Memory and Executive
Test (BMET21) Study.
Replication cohort. One hundred patients (71 male; mean
[SD] age 65.1 [9.9] years) were recruited from specialized stroke
services across the United Kingdom as part of 2 ongoing studies
determining cognitive impairment in SVD (SCANS20 and BMET
multicenter extension). For both studies, recruitment was from
acute stroke units and outpatient minor stroke/TIA services
between September 2009 and November 2013.
Non-SVD ischemic stroke population. Fifty patients with
nonlacunar ischemic stroke (28 male; mean [SD] age 63.5
[11.6] years), matched for disability level with the SVD cohorts, were
recruited from stroke clinics at St George’s Hospital, London, between
November 2010 and February 2013. Inclusion criteria were any cor-
tical infarction (with or without associated subcortical infarction), or
nonlacunar subcortical infarction .2 cm in maximum diameter.
Exclusion criteria included Fazekas leukoaraiosis grade .1 on
MRI.22 All cases were reviewed by a single consultant neurologist
and classified according to the TOAST (Trial of Org 10172 in Acute
Stroke Treatment) stroke classification23: large-artery 5 14%;
cardioembolic 5 26%; other 5 6%; and unknown 5 54%.
Review of MRIs showed that 35 (70%) had cortical infarction, and
15 (30%) had nonlacunar subcortical infarction. No patients were
tested during the acute stroke phase; 43 (86%) were tested at least 3
months poststroke, and all were tested at least 6 weeks poststroke.
Twenty percent of the non-SVD stroke patients met the GDS criteria
for depression.19
Healthy control population. A control group (85 male; mean
[SD] age 67.1 [9.4] years), consisting of 203 healthy individuals with-
out previous stroke or other major neurologic disorder, was recruited
by random sampling of family doctor practices in South London
between January 2012 and January 2013. All patients in the United
Kingdom are registered with a family doctor and therefore this is rep-
resentative of the community population. Eleven percent of the control
population met the GDS criteria for depression.
DTI SVD subgroup. A subset of patients with SVD (n5 101),
66 from the discovery cohort and 35 from the replication cohort,
all from the SCANS Study,20 underwent DTI in addition to
conventional MRI, as well as an extensive cognitive and func-
tional disability assessment.
Demographics of the patient and control groups are shown in
table 1.
Study protocol approvals, registrations, and patient consents.
All research was conducted as a part of studies approved by a UK
NHS ethics committee. Full written consent was obtained from
all participants.
Behavioral measures. All patient and control groups were assessed
using the same scales as follows. Depression was assessed using the
30-item GDS.19 This includes items with yes/no responses: for
example, “Do you feel that your life is empty?” and “Are you in
good spirits most of the time?” Data on depressive symptoms
were collected on a continuous scale of 0 to 30 rather than a
binary scale of depressed vs not depressed, so as to retain
maximum variance in the data.
QoL was assessed using the Stroke-Specific Quality of Life
Scale (SSQoL24). This scale was developed for use in stroke trials
with established internal reliability and sensitivity to change. For
the purpose of this study, the scale items were presented in the
present tense to reflect current experiences (e.g., “I often have to
stop and rest during the day”). Total QoL score was based on 11
of the 12 subscales (without the mood subscale to avoid overlap
with the depression scale). Scores were calculated pro-rata to
account for intermittent missing responses.
Disability was measured using the modified Rankin Scale
(mRS25), a 7-point rating scale developed specifically to mea-
sure disability during stroke, and the Barthel Activities of
Daily Living (ADL26) Scale, which covers levels of basic phys-
ical function and independent living. For the subgroup of pa-
tients with SVD in study 2, two additional aspects of behavior
were assessed (n 5 101; see table 1): higher-order living skills,
measured using the Instrumental Activities of Daily Living
(IADL) Scale (see reference 27), which focuses on abilities such
as managing finances or using public transportation; and global
cognition, which was tested using a broad cognitive assessment
undertaken by a neuropsychologist at the same time as measur-
ing other indices of function, producing an overall index of
performance across all tasks, as summarized in table e-1 on
the Neurology® Web site at Neurology.org.
Diffusion tensor imaging. DTI data were acquired on a 1.5T
General Electric Signa HDxtMRI system (General Electric, Milwau-
kee, WI) as previously reported.20 Axial single-shot spin echo planar
images (EPIs) (echo time 5 93.4 milliseconds; repetition time 5
15,600 milliseconds) were acquired to give isotropic voxels and whole
brain coverage (2.5 mm3; field of view 5 240 3 240 mm2;
acquisition matrix 5 96 3 96). After 4 acquisitions without
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diffusion weighting (b 5 0 s$mm22), diffusion-sensitized images
were acquired with gradients applied (b 5 1,000 s$mm22) in
25 noncollinear directions. This was repeated to acquire a further 4
b 5 0 s$mm22 images and the negative of the 25 directions. The 8
b 5 0 s$mm22 images were coregistered and averaged to give a
T2-weighted EPI, which was used to realign diffusion images and
remove eddy-current distortions using the FSL Linear Image
Registration Tool (FLIRT, FMRI Software Library, FSL version
4.1; FMRIB Analysis Group, Oxford, UK, http://www.fmrib.ox.
ac.uk/fsl).28 The geometric average of the positive and negative
acquisitions was taken to eliminate gradient cross-terms.29
FSL’s TBSS software30 was used to analyze diffusion data.
EPIs were brain-extracted using BET (Brain Extraction Tool)
and fractional anisotropy (FA) images created by fitting a tensor
model using FDT. All subjects’ FA data were then nonlinearly
aligned into a common space and then projected to a mean FA
skeleton. Median FA was calculated as the 50th percentile of
nonzero voxels from each subject’s TBSS skeleton. We used
median FA as an index of white matter structural integrity
throughout the whole brain.
Statistical analysis. Variables were corrected such that higher
values equated to higher levels of depressive symptoms, disability,
functional disability, and cognitive deficit, and lower levels of
QoL and white matter integrity. Missing data were examined
and found to be few and sporadic (SSQoL 5 0.4%; 30-item
GDS 5 2.4%; mRS 5 0.4%; ADL 5 0.6%; IADL 5 1%;
median FA 5 0%; global cognition 5 0%). Therefore, these
data were imputed using an expectation maximization
algorithm, as part of SPSS’s Missing Value Analysis Tool, for
each variable and group separately.
Study 1. To investigate simultaneously the relationships
among disability, depression, and QoL for each study population,
analyses were performed using AMOS 5.0 SEM (structural equa-
tion modeling) software. Disability was defined as a latent variable
with loadings from 2 disability measures, ADL and mRS.
Table 1 Patient demographics and results from the different assessments
SVD discovery SVD replication Non-SVD stroke Healthy controls SVD-DTI subgroup
No. 100 100 50 203 101
Age, y, mean (SD); range 71.1 (8.5); 46–89 65.1 (9.9); 44–88 63.5 (11.6); 39–86 67.1 (9.4); 42–84 70.1 (9.5); 46–88
Sex, male, n (%) 60 (60) 71 (71) 28 (56) 85 (42) 70 (69)
Time since last stroke, y, mean (SD) 3.7 (5.6) 1.5 (3.0) 0.5 (0.9) — 2.7 (5.5)
Stroke subtype, n (%)
Large-artery 0 (0) 0 (0) 7 (14) — 0 (0)
Cardioembolic 0 (0) 0 (0) 13 (26) 0 (0)
Small-vessel 100 (100) 100 (100) 0 (0) 100 (100)
Other 0 (0) 0 (0) 3 (6) 0 (0)
Indeterminate 0 (0) 0 (0) 27 (54) 0 (0)
Stroke location, n (%)
Cortical 0 (0) 0 (0) 35 (70) — 0 (0)
Subcortical 100 (100) 100 (100) 15 (30) 100 (100)
Leukoaraiosis grade, n (%)
0 6 (6) 32 (32) — — 3 (3)
1 19 (19) 13 (13) 13 (13)
2 45 (45) 21 (21) 46 (45)
3 30 (30) 34 (34) 39 (39)
Disability mRS, mean (SD) 1.2 (1.3) 1.0 (1.0) 1.29 (1.0) 0.60 (0.8) 1.1 (1.0)
Hypertensive treatment, n (%) 87 (87) 80 (80) 34 (71) 63 (31) 89 (88)
Treated hypercholesterolemia, n (%) 88 (88) 81 (81) 43 (88) 57 (28) 91 (90)
Diabetes mellitus, n (%) 23 (23) 39 (39) 14 (28) 18 (9) 37 (37)
Smoking, n (%)
Never 41 (41) 43 (43) 25 (50) 122 (60) 45 (45)
Ex 39 (39) 39 (39) 19 (38) 60 (30) 37 (37)
Current 20 (20) 18 (18) 6 (12) 20 (10) 18 (18)
Treated depression, current, n (%) 4 (4) 7 (7) 1 (2) 11 (5) 7 (7)
30-Item GDS, mean (SD) 8.2 (6.5) 7.9 (6.8) 5.5 (5.7) 4.3 (4.9) 8.9 (6.6)
SSQoL minus the mood subscale, mean (SD) 191.6 (34.4) 181.1 (30.3) 184.5 (28.8) 200.3 (18.4) 190.5 (31.1)
Abbreviations: DTI 5 diffusion tensor imaging; GDS 5 Geriatric Depression Scale; mRS 5 modified Rankin Scale; SSQoL 5 Stroke-Specific Quality of Life
Scale; SVD 5 small-vessel disease.
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Depression and QoL were defined as observed variables with total
scores taken from the 30-item GDS and SSQoL, respectively.
The variance in the endogenous variables accounted for by age
and sex was controlled for in the models. Each model had 21
sample moments and 15 parameters to be estimated 5 6 degrees
of freedom. For robustness and to account for any nonnormality
in the data, bootstrap analyses (using nonparametric resampling,
2,000 repetitions) were conducted for direct and indirect effects
in the model.
Study 2. An extended model using the DTI data was created to
determine the role of loss of white matter integrity on depression and
disability, as well as the role of IADL and global cognition. For this
analysis, a subgroup of patients with SVD taken from the discovery
and replication cohorts were included (n5 101, age 70.1 [9.5] years,
sex 70 male; see table 1). The extended model had 28 sample
moments and 22 parameters to be estimated5 6 degrees of freedom.
For robustness and to account for any nonnormality in the data,
bootstrap analyses (using nonparametric resampling, 2,000 repeti-
tions) were conducted for direct and indirect effects in the model.
RESULTS Study 1: Depression, disability, and QoL.
We hypothesized in our initial theoretical model that
in SVD, both depression and disability would directly
affect QoL, and that disability would affect depres-
sion leading to an indirect effect on QoL. We also
included age and sex in the model to account for
group differences.
SVD discovery cohort. Path analyses indicated that the
direct path from depression to QoL was highly signifi-
cant (b 5 0.53, p , 0.001; 95% confidence interval
[CI]5 0.41, 0.64) as was the direct path from disability
to QoL (b 5 0.53, p, 0.001; 95% CI5 0.41, 0.66).
However, the direct path between disability and depres-
sion was not significant (b5 0.19, p5 0.08; 95%CI5
20.02, 0.41). The indirect path from disability to QoL
via depression was not significant (b 5 0.10, p5 0.06;
95% CI 5 20.01, 5.8).
SVD replication cohort. The initial model was applied
to the replication SVD cohort. Path analyses revealed
a very similar pattern of results to that seen in the dis-
covery cohort. The direct paths from depression to
QoL (b 5 0.51, p , 0.001; 95% CI 5 0.36,
0.67) and disability to QoL (b 5 0.58, p , 0.001;
95% CI 5 0.37, 0.78) were highly significant with
similar b values to the discovery group. The direct
path between disability and depression was not sig-
nificant (b 5 0.21, p 5 0.15; 95% CI 5 20.07,
0.49) and the indirect path from disability to QoL via
depression was also not significant (b 5 0.11, p 5
0.13; 95% CI 5 20.03, 0.13). See figure 1.
Non-SVD ischemic stroke. When the same model was
applied to the non-SVD stroke group, there was a
different pattern of results to that seen in SVD. The
direct path from depression to QoL was highly
significant (b 5 0.67, p , 0.001; 95% CI 5 0.22,
0.88) and the direct path from disability to QoL was
significant (b 5 0.25, p , 0.05; 95% CI 5 0.01,
0.57). In addition, the non-SVD group showed a
highly significant path from disability to depression
(b 5 0.47, p , 0.05; 95% CI 5 0.07, 0.74) and a
significant indirect path from disability to QoL via
depression (b 5 0.31, p 5 0.01; 95% CI 5 0.13,
0.55). See figure 2.
Control group. The results for the control group showed
significant paths from depression toQoL (b5 0.45, p5
0.003; 95% CI 5 0.26, 0.60), disability to QoL (b 5
0.43, p 5 0.002; 95% CI 5 0.23, 0.63), and from
disability to depression (b 5 0.32, p 5 0.007; 95%
CI 5 0.10, 0.59). There was also a significant indirect
effect of disability onQoL via depression (b5 0.14, p5
0.004; 95% CI 5 0.05, 0.26). See figure 3.
Time from stroke analysis. Because time from last
stroke was not matched between groups, a regression
analysis was performed in SPSS version 19 (IBM
Corp., Armonk, NY) to determine whether time
from stroke had an effect on depression. The results
Figure 1 SVD models
(A) SVD exploratory model of the relationships among physical disability, depression, and
reduction in QoL, in SVD. (B) SVD replication analysis of model 1 in a second independent
SVD patient group. Standardized b weights are shown for each path. **Significant at the
0.001 level. For depression, higher5worse depression; QoL reduction, higher5 poorer QoL;
disability, higher 5 worse disability. ADL5 Activities of Daily Living; mRS 5modified Rankin
Scale; QoL 5 quality of life; SVD 5 small-vessel disease.
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showed that there was no relationship for the SVD
discovery cohort (b 5 0.01, p 5 0.947), the SVD
replication cohort (b5 0.06, p5 0.580), or the non-
SVD cohort (b 5 20.1, p 5 0.456).
Study 2: Extended model incorporating DTI data. In the
subgroup of participants with SVD who underwent
DTI MRI, we added median FA (a measure of global
white matter damage), global cognitive deficit, and
functional disability to the model. The analysis re-
vealed significant paths from median FA to depres-
sion (b 5 0.25, p 5 0.03; 95% CI 5 0.03, 0.47),
disability (b 5 0.40, p 5 0.001; 95% CI 5 0.22,
0.56), and global cognition (b 5 0.36, p 5 0.004;
95% CI 5 0.13, 0.54). There was no significant
direct path from FA to QoL (b 5 0.05, p 5 0.48;
95% CI 5 20.10, 0.21); however, there was a sig-
nificant indirect effect of FA on QoL via other func-
tional variables (b 5 0.36, p 5 0.001; 95% CI 5
20.03, 0.19). There was also a significant indirect
path to functional disability via global cognition
(b 5 0.09, p 5 0.005; 95% CI 5 0.02, 0.19). See
figure 4.
DISCUSSION The results of study 1 demonstrated
that, in SVD, depression had a major effect on
QoL, as did physical disability. However, the magni-
tude of the depressive symptoms was not significantly
related to the degree of disability in this population.
This was confirmed in a replication analysis of an
independent sample, with strikingly similar results.
By contrast, the same analysis in a stroke population
in whom stroke was due to causes other than SVD
and in whom radiologic evidence of SVD was
excluded on MRI, found a significant relationship
between depressive symptoms and degree of physical
disability, in addition to the relationship between
depression and QoL and disability and QoL. Taken
together, these findings suggest that in stroke patients
without SVD, disability is an important causal factor
in depression, while in SVD stroke, other factors spe-
cific to this stroke subtype have a causal role.
The results of study 2, which included DTI to
measure white matter ultrastructural damage, support
the hypothesis that one factor that explains the spe-
cific association of SVD with depression is white mat-
ter damage. When median FA, an index of global
white matter integrity, was added to the model along
with global cognition and functional disability, the
results showed that loss of white matter integrity was
associated with depressive symptoms. In addition, FA
had a significant direct effect on physical disability
and global cognition, a significant indirect effect on
QoL via physical disability and depression, and a signif-
icant indirect effect on functional disability via global
cognition. These findings highlight the major impact
of white matter damage on function, and are consistent
with white matter tract disruption having a direct role
in depression in patients with SVD.
Previous studies have reported that white matter hy-
perintensities are associated with late-onset depression31
and have shown that radiologic evidence of SVD is
associated with depression in stroke populations.10,11
These results have been used to suggest that white mat-
ter ischemia and subsequent white matter tract damage
produces disruption of cortical-subcortical connections
underlying complex networks involved in mood regu-
lation.32,33 Understanding the interrelationships of
other factors such as physical disability on SVD and
depression is complex, and studies have shown mixed
results.3,16 In this report, we identified differential mod-
els of depression, disability, and QoL in stroke popula-
tions with and without SVD, and demonstrated the
direct role of white matter damage on depression in
an SVD population. These findings suggest that SVD
may have a direct role in driving depression. Further
studies focused on specific regions are required to better
Figure 2 Non-SVD stroke model
Replication analysis in a non-SVD stroke patient group. Standardized b weights are shown
for each path. *Significant at the 0.05 level; **significant at the 0.001 level. ADL5Activities
of Daily Living; mRS 5 modified Rankin Scale; QoL 5 quality of life; SVD 5 small-vessel
disease.
Figure 3 Control model
Replication analysis in a healthy older adult group. Standardized b weights are shown for
each path. **Significant at the 0.001 level. ADL5 Activities of Daily Living; mRS5modified
Rankin Scale; QoL 5 quality of life.
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understand the disruption of specific pathways and may
provide further evidence for the vascular depression
hypothesis.
Our results have some clinical implications. First,
they highlight that both depression and disability lead
to significant reductions in QoL across stroke sub-
types. This is important given the high rates of pa-
tients meeting the clinical criteria for depression in
our sample compared with the numbers receiving
treatment. Second, they suggest that mood may be
an important outcome of SVD.
The use of subjective measures, such as the GDS
and the SSQoL, may produce a reporting bias related
to the presence of anosognosia, or neglect associated
with right hemisphere lesions. This is not an issue
in the group of patients with SVD, who do not dis-
play these symptoms, but could influence results in
the stroke group.
SVD appears to be a specific risk factor for depres-
sion, independent of disability levels, and this associ-
ation is at least partially mediated by reduced white
matter integrity. Furthermore, expectations that
depression results from physical or cognitive disability
may contribute to the underrecognition of depression
in this patient group. Depression is an important con-
sequence of SVD, and further studies to understand
the mechanisms of depression in this population as
well as treatment trials may result in improved QoL
in this patient group.
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Figure 4 Extended SVD model including functional disability, global cognitive deficit, and white matter
damage (taken as median FA with signs reversed)
Standardized b weights are shown for each path. For clarity, only paths significant at the 0.05 level are presented in black,
and paths approaching significance are presented in gray. ADL 5 Activities of Daily Living; FA 5 fractional anisotropy;
mRS 5 modified Rankin Scale; QoL 5 quality of life; SVD 5 small-vessel disease.
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